Sentante successfully completed a GLP study!
April 17, 2024
April 17, 2024
Our animal study exceeded expectations and showcased extraordinary results. This milestone marks an important step forward in our journey.
We want to say a heartfelt thank you to all amazing people in Veranex for their incredible expertise and unwavering support during the study. Also, to Lorenzo Patrone, Konstantinos Stavroulakis, Max Amor, Arturas Mackevicius and Giovanni F. Torsello! Your participation and invaluable feedback were instrumental in making this study a success.
Our latest
news and publications
news and publications
-
Read
Sentante accepted into FDA Total Product Life Cycle Advisory Program following Breakthrough Device DesignationFebruary 13, 2026 -
Read
Sentante Accelerates Remote Stroke Surgery Innovation With First Live TrialsDecember 12, 2025 -
Read
Critical Stroke Procedure Performed from Across the AtlanticNovember 11, 2025